# Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients

> **NCT05067608** · PHASE1,PHASE2 · COMPLETED · sponsor: **Singapore General Hospital** · enrollment: 17 (actual)

## Conditions studied

- Hypoproliferative Thrombocytopenia

## Interventions

- **BIOLOGICAL:** Control arm receiving normal (never before frozen) platelets as per current clinical practice
- **BIOLOGICAL:** Treatment arm receiving cryopreserved platelets

## Key facts

- **NCT ID:** NCT05067608
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-25
- **Primary completion:** 2021-03-24
- **Final completion:** 2021-03-24
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-10-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05067608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05067608, "Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05067608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*